Want to shun cigar?

    0
    183

    In a global study, scientists have found that medication therapy could increase the long-term success of smokers who are not yet ready to quit, but are willing to cut back on cigarettes.

    Dr. Ebbert said that smokers should know that varenicline could help in quitting smoking if they want to reduce their smoking prior to completely stopping. It’s an effective and safe way to increase long-term smoking cessation.

    A study of more than 1,500 cigarette reported the effects of the prescription medication varenicline (Chantix) for increasing smoking abstinence rates among smokers who wanted to reduce the number of cigarettes they smoked before trying to quit completely.

    Jon Ebbert, M.D., associate director for research in the Mayo Clinic Nicotine Dependence Center, and lead author on the study, said that this opened the door to treatment for approximately 14 million smokers who have no intention of quitting in the next 30 days but are willing to reduce their smoking rate while working toward a quit attempt.

    T Dr. Ebbert said that smokers should know that varenicline could help in quitting smoking if they want to reduce their smoking prior to completely stopping. It’s an effective and safe way to increase long-term smoking cessation.

    he researchers found that 760 participants receiving varenicline were greater than four times more likely to quit than the 750 participants receiving placebo at six months (32.1 % vs. 6.9 %) and over two times more likely to quit than participants receiving a placebo at 12 months (27.0 % vs. 9.9 %).

    Previous research has linked Chantix to side effects including suicidal thoughts, erratic behavior and drowsiness. The U.S. Food and Drug Administration placed a black box warning – its most severe and restrictive warning – on the product in 2009, highlighting the drug’s adverse neuropsychological effects.

    People with a history of major depressive or anxiety disorder, suicidal behavior, panic disorder, post-traumatic stress disorder, schizophrenia, or psychosis were excluded from the study, published in the American Medical Association’s journal JAMA.